FC
TMO icon

Farringdon Capital’s Thermo Fisher Scientific TMO Stock Holding History

Farringdon Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,949
Closed -$1.6M – 648
2025
Q2 		$1.6M Buy
3,949
+1,190
+43% +$498K 0.54% 27
2025
Q1 		$1.37M Buy
2,759
+1,705
+162% +$923K 0.69% 24
2024
Q4 		$548K Buy
+1,054
New +$579K 0.23% 124

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Farringdon Capital's TMO Position: Q3 2025 in Review

Farringdon Capital sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 3,949 shares — an estimated $1.6M sold.

Farringdon Capital first reported a position in TMO in Q4 2024 and held it in 3 quarters. The position peaked at $1.6M in Q2 2025. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Farringdon Capital reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Farringdon Capital sold 3,949 Thermo Fisher Scientific shares in Q3 2025, an estimated $1.6M.
  • Farringdon Capital first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 3 quarters.
  • Farringdon Capital's Thermo Fisher Scientific position peaked at $1.6M in Q2 2025.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Farringdon Capital's 13F filing for Q3 2025, filed 13 Nov 2025.